265 related articles for article (PubMed ID: 18552490)
21. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.
Miller CL; Kerr T; Frankish JC; Spittal PM; Li K; Schechter MT; Wood E
Subst Use Misuse; 2006; 41(2):199-210. PubMed ID: 16393742
[TBL] [Abstract][Full Text] [Related]
22. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users.
Kerr T; Fairbairn N; Tyndall M; Marsh D; Li K; Montaner J; Wood E
Drug Alcohol Depend; 2007 Feb; 87(1):39-45. PubMed ID: 16959438
[TBL] [Abstract][Full Text] [Related]
23. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of HIV, syphilis and HCV, and low methadone maintenance treatment in a migrant population in Beijing.
Li D; Chu P; Yang Y; Li S; Ruan Y; Liu Z; Cao X; Lu L; Jia Z
J Addict Med; 2012 Dec; 6(4):311-7. PubMed ID: 23041679
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada.
Johnson S; MacDonald SF; Cheverie M; Myrick C; Fischer B
Drug Alcohol Depend; 2012 Jul; 124(1-2):172-6. PubMed ID: 22265193
[TBL] [Abstract][Full Text] [Related]
26. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
[TBL] [Abstract][Full Text] [Related]
27. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.
Wood E; Tyndall MW; Zhang R; Montaner JS; Kerr T
Addiction; 2007 Jun; 102(6):916-9. PubMed ID: 17523986
[TBL] [Abstract][Full Text] [Related]
28. Value for money in drug treatment: economic evaluation of prison methadone.
Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
[TBL] [Abstract][Full Text] [Related]
29. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
30. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.
Dobler-Mikola A; Hättenschwiler J; Meili D; Beck T; Böni E; Modestin J
J Subst Abuse Treat; 2005 Dec; 29(4):259-65. PubMed ID: 16311178
[TBL] [Abstract][Full Text] [Related]
31. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
Bloor M; McIntosh J; McKeganey N; Robertson M
Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
[TBL] [Abstract][Full Text] [Related]
32. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
Larney S; Toson B; Burns L; Dolan K
Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442
[TBL] [Abstract][Full Text] [Related]
33. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
34. Impact of incarceration on rates of methadone use in a community recruited cohort of injection drug users.
Koehn JD; Bach P; Hayashi K; Nguyen P; Kerr T; Milloy MJ; Rieb L; Wood E
Addict Behav; 2015 Jul; 46():1-4. PubMed ID: 25746159
[TBL] [Abstract][Full Text] [Related]
35. Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.
Huang YF; Kuo HS; Lew-Ting CY; Tian F; Yang CH; Tsai TI; Gange SJ; Nelson KE
Addiction; 2011 Aug; 106(8):1437-45. PubMed ID: 21438941
[TBL] [Abstract][Full Text] [Related]
36. Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.
Zeiler I; Langlands T; Murray JM; Ritter A
Drug Alcohol Depend; 2010 Aug; 110(3):228-33. PubMed ID: 20430537
[TBL] [Abstract][Full Text] [Related]
37. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
[TBL] [Abstract][Full Text] [Related]
38. Incarceration and drug use patterns among a cohort of injection drug users.
DeBeck K; Kerr T; Li K; Milloy MJ; Montaner J; Wood E
Addiction; 2009 Jan; 104(1):69-76. PubMed ID: 19133890
[TBL] [Abstract][Full Text] [Related]
39. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
40. Impact of methadone on drug use and risky sex in China.
Qian HZ; Hao C; Ruan Y; Cassell HM; Chen K; Qin G; Yin L; Schumacher JE; Liang S; Shao Y
J Subst Abuse Treat; 2008 Jun; 34(4):391-7. PubMed ID: 17869049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
